Pharmacological Research (Mar 2023)
Corrigendum to ‘Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein’ [Pharmacol. Res. 175 (2022) 105975]
Abstract
No abstracts available.
Pharmacological Research (Mar 2023)